TPG and Blackstone Plan Sale of Hologic Surgical Business for Over $4 Billion
Investment firms TPG and Blackstone are reportedly planning to sell the surgical business unit of Hologic, seeking a valuation exceeding $4 billion. This potential divestiture aims to help repay debt and recoup funds from their acquisition of the medical technology company last year. The sale process is currently in its early stages, and there is no certainty that a deal will be finalized. In April of this year, TPG and Blackstone, in conjunction with Mubadala Investment Company and GIC, completed the privatization of Hologic in a deal valued at $18.3 billion.
The planned sale of Hologic's surgical business by TPG and Blackstone, less than a year after their $18.3 billion privatization, suggests a strategic re-evaluation of their investment portfolio or a need to optimize capital allocation. This move could reflect a broader trend in private equity where assets are acquired with the intention of restructuring or divesting specific units to maximize returns. The timing and valuation sought indicate potential shifts in market sentiment or perceived value for specialized medical technology assets. Investors will be watching to see if the sale proceeds and at what valuation, which could provide insights into the market's appetite for such assets and the effectiveness of the firms' initial investment thesis.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.